174 related articles for article (PubMed ID: 20673487)
1. [Clinical significance and diagnostic value of Survivin autoantibody in non-small cell lung cancer patients].
Ma L; Yue W; Zhang L; Wang Y; Zhang C; Yang X
Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):706-12. PubMed ID: 20673487
[TBL] [Abstract][Full Text] [Related]
2. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
3. Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status.
Broodman I; VanDuijn MM; Stingl C; Dekker LJ; Germenis AE; de Koning HJ; van Klaveren RJ; Aerts JG; Lindemans J; Luider TM
Cancer Immunol Res; 2016 Feb; 4(2):165-72. PubMed ID: 26659304
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of the Survivin Autoantibody in Four Types of Malignancies.
Xiu Y; Sun B; Jiang Y; Wang A; Liu L; Liu Y; Sun S; Huangfu M
Genet Test Mol Biomarkers; 2018 Jun; 22(6):384-389. PubMed ID: 29924656
[TBL] [Abstract][Full Text] [Related]
5. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer.
Lam S; Boyle P; Healey GF; Maddison P; Peek L; Murray A; Chapman CJ; Allen J; Wood WC; Sewell HF; Robertson JF
Cancer Prev Res (Phila); 2011 Jul; 4(7):1126-34. PubMed ID: 21733826
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer.
Chen JS; Chen KT; Fan WC; Yu JS; Chang YS; Chan EC
Clin Chem Lab Med; 2010 May; 48(5):719-25. PubMed ID: 20178447
[TBL] [Abstract][Full Text] [Related]
8. An Autoantibody Against Human DNA-Topoisomerase I Is a Novel Biomarker for Non-Small Cell Lung Cancer.
Wu WB; Yie SM; Ye SR; Xie K; Zhang JB; Cao M; Chen J; He X; Ma XL; Zhang J
Ann Thorac Surg; 2018 Jun; 105(6):1664-1670. PubMed ID: 29453962
[TBL] [Abstract][Full Text] [Related]
9. Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer.
Fawzy A; Gaafar R; Kasem F; Ali SS; Elshafei M; Eldeib M
J Egypt Natl Canc Inst; 2012 Mar; 24(1):41-5. PubMed ID: 23587231
[TBL] [Abstract][Full Text] [Related]
10. [Prokaryotic expression, purification and antigenicity identification of recombinant human survivin protein].
Yin X; Wang W; Tian R; Xu Y; Yan J; Zhang W; Gao J; Yu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):877-81. PubMed ID: 23948420
[TBL] [Abstract][Full Text] [Related]
11. [Detecting EGFR autoantibodies in serums of NSCLC patients with peptide array].
Li Y; Yue W; Wang Y; Zhang L; Gu M; Xu S
Zhongguo Fei Ai Za Zhi; 2010 Jul; 13(7):727-30. PubMed ID: 20673491
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma.
Ma L; Yue W; Teng Y; Zhang L; Gu M; Wang Y
Dis Markers; 2013; 35(5):317-25. PubMed ID: 24167380
[TBL] [Abstract][Full Text] [Related]
13. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
[TBL] [Abstract][Full Text] [Related]
14. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer.
Bai Y; Shen W; Zhu M; Zhang L; Wei Y; Tang H; Zhao J
J Cell Biochem; 2019 Jan; 120(1):105-114. PubMed ID: 30216488
[TBL] [Abstract][Full Text] [Related]
15. Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer.
Wang T; Liu H; Pei L; Wang K; Song C; Wang P; Ye H; Zhang J; Ji Z; Ouyang S; Dai L
Clin Immunol; 2020 Jan; 210():108262. PubMed ID: 31629809
[TBL] [Abstract][Full Text] [Related]
16. Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer.
Yao X; Jiang H; Zhang C; Wang H; Yang L; Yu Y; Yu J; Shi B; Shen Z; Gao H; Chen Z; Tian S; Lu S; Li Z; Gu J
Biomarkers; 2010 Mar; 15(2):128-34. PubMed ID: 19839718
[TBL] [Abstract][Full Text] [Related]
17. Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients.
Cressey R; Pimpa S; Chewaskulyong B; Lertprasertsuke N; Saeteng S; Tayapiwatana C; Kasinrerk W
BMC Biotechnol; 2008 Feb; 8():16. PubMed ID: 18284706
[TBL] [Abstract][Full Text] [Related]
18. [OLC1 protein levels in plasma of patients with non-small cell lung cancer and its clinical application].
Yang L; Xiao T; Tan J; Chen S; Gao Y; Cheng S; Liu X; Sun K
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):362-5. PubMed ID: 25030592
[TBL] [Abstract][Full Text] [Related]
19. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers.
Monzó M; Rosell R; Felip E; Astudillo J; Sánchez JJ; Maestre J; Martín C; Font A; Barnadas A; Abad A
J Clin Oncol; 1999 Jul; 17(7):2100-4. PubMed ID: 10561264
[TBL] [Abstract][Full Text] [Related]
20. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer.
Farlow EC; Patel K; Basu S; Lee BS; Kim AW; Coon JS; Faber LP; Bonomi P; Liptay MJ; Borgia JA
Clin Cancer Res; 2010 Jul; 16(13):3452-62. PubMed ID: 20570928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
